Vancomycin-resistant enterococcus (VRE) are increasingly important pathogens in stem cell transplant (SCT). In all, 61 pediatric SCT patients had surveillance stool cultures for VRE between July 1999 ...

Researchers have developed a novel combination therapy using an anticancer agent, mitoxantrone (MTX), together with an antibiotic, vancomycin, for treating bacteria that are resistant to the ...

Please provide your email address to receive an email when new articles are posted on . The array of health care-associated infections, ranging from catheter-associated UTIs to Clostridioides ...

Enterococci can cause urinary tract, wound, and soft tissue infections. They are also associated with bacteremia which can lead to endocarditis in previously damaged cardiac valves. Enterococci are ...

Vancomycin-resistant enterococci are a common cause of healthcare-associated infection. A literature review was conducted to understand the current evidence and support nurses and other health ...

When the CDC released the 2019 Antibiotic Resistance Threats in the United States report, VRE was listed as a serious threat. Enterococci are bacteria that are normally present in the human intestines ...

WEST LAFAYETTE, Ind. – Vancomycin-resistant enterococcus (VRE) is among the leading causes of hospital-acquired infections in the United States. An estimated 20,000 people in the U.S. become infected ...

V-161, a novel compound targeting the Na+ -V-ATPase enzyme in vancomycin-resistant Enterococcus faecium (VRE), significantly reduces bacterial growth and colonization. A recent study has demonstrated ...

To combat the rise of drug-resistant bacteria, researchers are examining how one superbug adapts to fight an antibiotic of last resort. Scientists say they tracked the biochemical changes that the ...

A drug-resistant type of bacteria that has adapted to health care settings evolved in the past several years to weaponize an antimicrobial genetic tool, eliminating its cousins and replacing them as ...